Mix-and-Match Vaccine Platform May Boost Immune Response & Duration

A consortium to begin the development of the next COVID-19 vaccine is underway at The Infections Disease Research Institute (IDRI). The Washington-based non-profit is working to ensure the next generation of the vaccine can withstand more moderate temperatures and improve immunity for longer periods of time without additional booster shots.

“The first-generation vaccines were incredibly important, but they are not sufficient to take us through this pandemic or for the next pandemic,” said IDRI CEO Corey Casper, M.D., MPH.

READ THE STORY at BioSpace »